Ask us a question
520 547-3440
[email protected]
Subscribe
Critical Path Institute
Home
About
HOW WE OPERATE
Timeline
People
FAQ
Employment
Annual Reports
10-year Anniversary
Programs
Sharing Knowledge that Leads to Innovation
BmDR
Biomarker Data Repository
CFAST
Coalition for Accelerating Standards & Therapies
CPAD
Critical Path For Alzheimer’s Disease
CPP
Critical Path for Parkinson’s
CPTR
Critical Path to TB Drug Regimens
DCC
Data Collaboration Center
D-RSC
The Duchenne Regulatory Science Consortium
ePRO Consortium
Electronic Patient-Reported Outcome Consortium
HD-RSC
Huntington’s Disease Regulatory Science Consortium
INC
International Neonatal Consortium
MSOAC
Multiple Sclerosis Outcome Assessments Consortium
PKD
Polycystic Kidney Disease Outcomes Consortium
PRO Consortium
Patient-Reported
Outcome Consortium
PSTC
Predictive Safety Testing Consortium
PTC
Pediatric Trials Consortium
T1D
Type 1 Diabetes Consortium
TB-PACTS
TB-Platform for Aggregation of Clinical TB Studies
TTC
Transplant Therapeutics Consortium
Successes
News & Events
Events
News
Videos
Publications
Presentations
Press Releases
Contact
Donate
News
Home
>
News & Events
>
Publications
>
C-Path
>
Charting A Path Toward Combination Therapy For Alzheimer’s Disease
News
January 1, 2015
PRINT
PDF
Charting A Path Toward Combination Therapy For Alzheimer’s Disease
Share this
Related Posts
Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease
x
